Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
These medications activate GLP-1 receptors (and sometimes GIP receptors), helping you feel fuller for a longer period, reducing cravings, and improving metabolic function
Still a bit more tired than usual but no other adverse side effects
Gentle exercise such as walking, swimming, or yoga promotes circulation, enhances mood, and supports metabolic health
I guarantee you theres been no study of their particular product randomized to a large number of people demonstrating that that actually happens, said Cohen, whos investigated dietary supplement safety for decades
